Skip to main content

Famotidine

NDC 0832-6045 · Upsher-Smith Laboratories, LLC

Generic nameFamotidine

Dosage formPOWDER, FOR SUSPENSION

RouteORAL

Active ingredient(s)FAMOTIDINE

Strength40 mg/5mL

Pharmacologic classHistamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]

Marketing categoryANDA

Packages

0832-6045-10 — 100 mL in 1 BOTTLE (0832-6045-10)

0832-6045-15 — 150 mL in 1 BOTTLE (0832-6045-15)

0832-6045-50 — 50 mL in 1 BOTTLE (0832-6045-50)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0363-4400 — Famotidine, 0363-5300 — Famotidine, 0363-9607 — Famotidine, 0527-5190 — Famotidine, 0536-1298 — Famotidine, 0615-8558 — Famotidine, 0615-8559 — Famotidine, 0641-6021 — Famotidine, 0641-6022 — Famotidine, 0641-6023 — Famotidine, 0904-5529 — Famotidine, 0904-5780 — Famotidine, 0904-7193 — Famotidine, 10267-5689 — Famotidine, 10267-5690 — Famotidine, 11673-697 — Famotidine, 11822-0500 — famotidine, calcium carbonate and magnesium hydroxide, 11822-1014 — famotidine, 11822-1194 — Famotidine, 11822-6123 — famotidine, +401 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels